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Abstract 
 
Objective 
Studies reporting an association between treatment delay and outcome for patients with 
STEMI have generally not included patients treated by a PPCI service that systematically 
delivers reperfusion therapy to all eligible patients. We set out to determine the association of 
CTB time with 30-day mortality after PPCI in a contemporary series of patients treated within 
a national reperfusion service. 
 
Methods 
We analysed data on 16907 consecutive patients with STEMI treated by PPCI in England and 
Wales in 2011 with CTB times of 6 hours or less. 
 
Results 
The median CTB and DTB times were 111 and 41 minutes, respectively, with 80.9% of 
patients treated within 150 minutes of the call for help. An out of hours call time (58.2% of 
patients) was associated with a 10-minute increase in CTB time whereas inter-hospital 
transfer for PPCI (18.5% of patients) was associated with a 49-minute increase in CTB time. 
CTB time was independently associated with 30-day mortality (p<0.0001) with a hazard ratio 
of 1.95 (95% CI 1.54 to 2.47) for a CTB time of >180-240 minutes compared to ≤90 minutes. 
The relationship between CTB time and 30-day mortality was influenced by patient risk 
profile with a greater absolute impact of increasing CTB times on mortality in high-risk 
patients. 
 
Conclusions 
CTB time is a useful metric to assess the overall performance of a PPCI service. Delays to 
reperfusion remain important even in the era of organised national PPCI services with rapid 
treatment times and efforts should continue to minimize treatment delays. 
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Key Questions 
 
What is already known about this subject? 
Primary percutaneous coronary intervention (PPCI) is the treatment of choice for patients 
presenting with acute ST segment elevation myocardial infarction (STEMI) provided it can be 
delivered in a timely fashion. Delays to treatment are associated with outcome and most 
efforts have focused on improvements in door to balloon time (DTB). 
 
What does this study add? 
We have demonstrated a strong independent association between call to balloon time (CTB) 
and 30-day mortality in an organised national PPCI service with short treatment delays. This 
relationship is influenced by the patient’s baseline risk profile such that those at highest risk 
are likely to benefit the most from reducing treatment delays. 
 
How might this impact on clinical practice? 
CTB time may more reliably assess the overall performance of a PPCI service as it includes 
the potentially modifiable components of both pre-hospital and hospital emergency care.
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Introduction 
 
National and international guidelines recommend that reperfusion therapy (fibrinolysis or 
primary percutaneous coronary intervention (PPCI)) for patients with acute ST segment 
elevation myocardial infarction (STEMI) is delivered as quickly as possible to restore 
coronary artery blood flow and limit myocardial necrosis. 1-3 In the United Kingdom (UK) the 
National Infarct Angioplasty Project (NIAP) recommended PPCI as the treatment of choice 
for patients with acute STEMI, provided it can be delivered in a timely fashion.4 Following 
publication of the NIAP report in 2008 there has been a rapid roll-out of PPCI services across 
the UK and in 2011 over 95% of STEMI cases treated by reperfusion therapy underwent 
PPCI.5 
 
The time interval between onset of symptoms due to STEMI and restoration of coronary 
blood flow is comprised of the ‘patient delay’ from onset of symptoms to the call for help, 
and the ‘system delay’ from the call for help to the delivery of reperfusion therapy. Several 
studies suggest that door to balloon (DTB) time (time from arrival in hospital to therapeutic 
instrumentation of the culprit coronary artery) correlates with in-hospital 6-9 and longer-term 
mortality 8,10,11 but this has not been confirmed in all studies.12-17 By contrast, call to balloon 
(CTB) time (time from the call for help to therapeutic instrumentation of the culprit coronary 
artery) may be influenced by the modifiable elements of the ‘system delay’.18 CTB time 
includes the time from the call for help to arrival of emergency services through to delivery of 
PPCI in hospital. Hence, CTB time may provide a more reliable assessment of the overall 
performance of a reperfusion service. 
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Methods 
 
The British Cardiovascular Intervention Society (BCIS) database records data from every PCI 
procedure in the UK, including patient demographics, clinical characteristics, procedural 
details and outcome data.19 Definitions for these variables are published in the BCIS PCI 
dataset.20 
 
Patient variables 
We analysed the BCIS database to determine factors associated with CTB time and 30-day 
mortality in patients with acute STEMI in England and Wales treated by PPCI during 2011, 
three years after introduction of the national PPCI programme.  
 
The CTB time was derived from the time of the call for help and the balloon time, which are 
recorded for each patient. The time of the call for help was defined as the time of the call for 
an ambulance for patients presenting in the community, or as the time of arrival at hospital for 
patients presenting directly to a hospital emergency department. For patients initially admitted 
to a hospital without PPCI capability, the call for help was defined by the first medical 
contact so that the CTB time included the time for transfer to a PPCI capable hospital.  The 
balloon time was defined as the time of use of the first device in the coronary artery.  
 
Patients were stratified according to their admission route; STEMI in the community admitted 
directly to a PPCI hospital (direct), STEMI in the community admitted to a non-PPCI hospital 
and then transferred to a PPCI hospital (transfer), STEMI whilst an in-patient in a non-PPCI 
hospital and then transferred to a PPCI hospital (non-PPCI IP), and STEMI whilst already an 
in-patient in a PPCI hospital (PPCI IP). Patients were also stratified into groups presenting 
‘in-hours’ (weekday 0800h-1800h) or ‘out of hours’ (weekday 1800h-0800h and weekends). 
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The National Health Service (NHS) number was used to facilitate mortality tracking via the 
Office of National Statistics (ONS) in England and Wales. All-cause mortality at 30 days was 
determined from deaths reported to ONS, a statutory requirement in England and Wales. 
 
Statistical analysis 
Univariable associations of baseline, procedural and timing variables with CTB time were 
assessed using linear regression. Variables independently associated with CTB time were 
identified using a manual forward stepwise approach with a p-value of 0.01 as the criterion 
for inclusion in the final multivariable model. A manual approach was used rather than an 
automated stepwise procedure to allow for clinical judgement. The linear relationship of 
quantitative variables was considered and variables were grouped into appropriate categories 
as necessary. 
 
To investigate the impact of CTB times and other factors on 30-day mortality, univariable and 
multivariable Cox models were fitted also using a manual forward stepwise approach, always 
including gender and CTB time. CTB time was not assumed to be linearly related to 30-day 
mortality across all times and hence was categorised into time intervals to reflect clinically 
relevant groups while ensuring sufficient numbers of patients in each group. 
 
To estimate the impact of admission route, calls made ‘out of hours’, centre procedural 
volume, and the components of symptom to balloon time (symptom to call, call to door and 
door to balloon time), the Cox model was extended to include these variables, excluding CTB 
time as appropriate.  
 
Data were missing for up to 14% of any one variable included in the models. In order to 
adjust for missing data, multiple imputation techniques with chained equations were used, 
assuming missingness is at random, with 10 imputations using all covariates in the model.21 
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To examine the relationship between CTB time and 30-day mortality for patients at different 
underlying risk, a multivariable model was created fitting CTB time as a continuous variable. 
The coefficients for this model were used to predict a patient’s 30-day mortality risk 
assuming a CTB time of 60 minutes and patients at the 25th, 50th and 75th centiles of risk were 
identified. By applying the coefficient for CTB time in the model to these risks, the predicted 
30-day mortality at each of these centiles could be determined for any CTB time up to 360 
minutes.   The predicted 30-day mortality was plotted against CTB time to illustrate the 
association between CTB time and mortality risk at different levels of underlying risk. 
 
All analyses were carried out with STATA version 13.1 (StataCorp, College Station, Texas).  
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Results 
 
In 2011 the BCIS database recorded 79433 PCI procedures in England and Wales including 
19534 procedures for patients with acute STEMI. We excluded patients with STEMI who 
were treated by fibrinolysis and subsequently underwent ‘rescue’ PCI, duplicate or repeat 
PPCI, missing call or balloon times, and CTB times greater than 6 hours. Our study cohort 
comprised 16907 patients with STEMI treated by PPCI (figure 1). 
 
The baseline demographic, clinical, procedural and timing characteristics are shown in table 
1. The mean CTB time was 121 minutes (median 111 minutes, IQR 90 to 139 minutes) and 
80.9% of patients were treated within 150 minutes of the call for help (figure 2). 
 
The mean DTB time for patients in the ‘direct’ cohort was 51 minutes (median 42 minutes, 
IQR 29 to 62 minutes). For patients in the ‘transfer’ cohort, the mean DTB time from first 
hospital admission was 133 minutes (median 123 minutes, IQR 95 to 161 minutes), but the 
mean DTB time from arrival at the PPCI centre was 39 minutes (median 34 minutes, IQR 25 
to 47 minutes). 
 
At 30 days 898 (5.3%) patients had died with 331 (2.0%) and 611 (3.6%) deaths at 24 hours 
and 7 days, respectively. Mortality rates at 30 days for patients with call to balloon times ≤90 
minutes, >90-150 minutes, and >150 minutes were 3.5%, 4.8% and 9.4%, respectively (figure 
3). 
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Table 1. Baseline demographic, clinical, procedural and timing factors 
 
Variable Number of 
patients 
Call to balloon 
(mean mins) 
Number of deaths 
at 30 days (%) 
All patients 16907 121.4 898 (5.3%) 
Age group, years <55 
   55-≤60 
   60-≤65 
   65-≤70 
   70-≤75 
   75-≤80 
   80-≤85 
   >85 
 
4614 (27.3%) 
2159 (12.8%) 
2353 (13.9%) 
2104 (12.4%) 
1889 (11.2%) 
1663 (9.8%) 
1216 (7.2%) 
906 (5.4%) 
117.8 
117.5 
118.6 
120.0 
124.4 
127.5 
130.2 
130.7 
103 (2.2%) 
72 (3.3%) 
92 (3.9%) 
96 (4.6%) 
106 (5.6%) 
129 (7.8%) 
132 (10.9%) 
167 (18.4%) 
Gender   Male 
   Female 
 
12509 (74.1%) 
4379 (25.9%) 
119.6 
126.7 
583 (4.7%) 
314 (7.2%) 
Diabetes  No 
   Yes 
 
14245 (86.8%) 
2166 (13.2%) 
120.3 
127.4 
652 (4.6%) 
179 (8.3%) 
Hypertension  No 
   Yes 
 
9630 (59.4%) 
6581 (40.6%) 
119.5 
123.2 
416 (4.3%) 
399 (6.1%) 
Hypercholesterolaemia No 
   Yes 
 
9868 (60.9%) 
6343 (39.1%) 
120.8 
121.3 
495 (5.0%) 
320 (5.0%) 
Smoking status  Never 
   Ex 
   Current 
 
5162 (33.7%) 
3887 (25.4%) 
6278 (41.0%) 
122.2 
122.1 
117.8 
281 (5.4%) 
195 (5.0%) 
194 (3.1%) 
Peripheral vascular No 
disease   Yes 
 
15681 (96.7%) 
530 (3.3%) 
120.7 
128.6 
733 (4.7%) 
82 (15.5%) 
Cerebrovascular No 
accident  Yes 
 
15577 (96.1%) 
634 (3.9%) 
120.6 
130.3 
740 (4.8%) 
75 (11.8%) 
Renal disease  No 
   Yes 
 
15235 (98.7%) 
205 (1.3%) 
120.9 
132.9 
708 (4.6%) 
44 (21.5%) 
Previous myocardial  No 
infarction  Yes 
 
13904 (88.1%) 
1876 (11.9%) 
120.2 
125.6 
669 (4.8%) 
144 (7.7%) 
Previous CABG No 
   Yes 
 
16174 (97.9%) 
342 (2.1%) 
121.0 
134.7 
839 (5.2%) 
24 (7.0%) 
Previous PCI  No 
   Yes 
 
15250 (92.0%) 
1323 (8.0%) 
121.1 
121.6 
783 (5.1%) 
72 (5.4%) 
Cardiogenic shock No 
pre-PCI   Yes 
 
15750 (93.4%) 
1109 (6.6%) 
120.5 
134.8 
502 (3.2%) 
392 (35.3%) 
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Ventilated pre-PCI No 
   Yes 
 
14354 (96.4%) 
541 (3.6%) 
119.2 
156.4 
595 (4.1%) 
227 (42.0%) 
Q wave on ECG No 
   Yes 
 
11774 (81.8%) 
2615 (18.2%) 
118.6 
129.0 
534 (4.5%) 
241 (9.2%) 
TIMI flow pre-PCI TIMI 0 
   TIMI 1 
   TIMI 2 
   TIMI 3 
 
10403 (73.7%) 
977 (6.9%) 
1280 (9.1%) 
1447 (10.3%) 
119.0 
121.2 
124.6 
129.7 
608 (5.8%) 
49 (5.0%) 
58 (4.5%) 
52 (3.6%) 
TIMI flow post-PCI TIMI 0 
   TIMI 1 
   TIMI 2 
   TIMI 3 
 
842 (5.8%) 
185 (1.3%) 
692 (4.7%) 
12850 (88.2%) 
120.7 
130.5 
127.6 
120.8 
109 (12.9%) 
40 (21.6%) 
87 (12.6%) 
552 (4.3%) 
 
Multi-vessel disease 1 vessel 
(>75% stenosis) ≥ 2 vessels 
 
11109 (70.5%) 
4655 (29.5%) 
119.3 
124.2 
410 (3.7%) 
433 (9.3%) 
Number of  Single 
vessels attempted Multi 
 
15278 (90.9%) 
1535 (9.1%) 
120.8 
126.6 
684 (4.5%) 
206 (13.4%) 
Arterial access  Radial 
   Femoral 
   Joint/other 
 
9065 (54.4%) 
7173 (43.1%) 
416 (2.5%) 
119.5 
123.7 
127.9 
282 (3.1%) 
554 (7.7%) 
47 (11.3%) 
Call time  Weekday 
    Weekend 
 
12167 (72.0%) 
4740 (28.0%) 
119.2 
127.1 
670 (5.5%) 
228 (4.8%) 
Call time  0800-1800 
   1800-0000 
   0000-0800 
 
9753 (57.7%) 
3213 (19.0%) 
3941 (23.3%) 
118.2 
124.5 
126.8 
529 (5.4%) 
168 (5.2%) 
201 (5.1%) 
Out of hours  No 
   Yes 
7062 (41.8%) 
9845 (58.2%) 
114.8 
126.1 
389 (5.5%) 
509 (5.2%) 
 
Admission route Direct 
   Transfer 
   Non-PPCI IP 
   PPCI IP 
 
12932 (77.2%) 
3102 (18.5%) 
372 (2.2%) 
355 (2.1%) 
112.4 
162.8 
123.1 
88.3 
655 (5.1%) 
178 (5.7%) 
27 (7.3%) 
30 (8.5%) 
Centre volume  <100 
   100-199 
   ≥200 
 
1237 (7.3%) 
1204 (7.1%) 
14466 (85.6%) 
 
108.1 
117.7 
122.9 
 
92 (7.4%) 
75 (6.2%) 
731 (5.1%) 
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Symptom to call (mins) ≤10 
   >10-30 
   >30-60 
   >60-120 
   >120-180 
   >180-360 
   >360 
2321 (14.2%) 
3206 (19.7%) 
2939 (18.0%) 
2821 (17.3%) 
1422 (8.7%) 
1727 (10.6%) 
1848 (11.3%) 
121.4 
118.7 
118.8 
118.0 
119.8 
123.7 
126.9 
207 (8.9%) 
143 (4.5%) 
131 (4.5%) 
113 (4.0%) 
68 (4.8%) 
81 (4.7%) 
108 (5.8%) 
 
Call to balloon (mins) ≤90 
   >90-105 
   >105-120 
   >120-135 
   >135-150 
   >150-180 
   >180-240 
   >240-360 
4351 (25.7%) 
3061 (18.1%) 
2784 (16.5%) 
2052 (12.1%) 
1423 (8.4%) 
1412 (8.4%) 
1232 (7.3%) 
592 (3.5%) 
 
 150 (3.4%) 
127 (4.1%) 
120 (4.3%) 
116 (5.7%) 
82 (5.8%) 
101 (7.2%) 
135 (11.0%) 
67 (11.3%) 
 
 
 
 
 
Diabetes: pre-hospital diagnosis 
Hypertension: treated or untreated 
Hypercholesterolaemia: total cholesterol >5.2 mmol/L or on lipid-lowering treatment 
Renal disease: creatinine > 200 µmol/L, functioning transplant or renal failure on dialysis 
CABG: coronary artery bypass graft surgery 
PCI: percutaneous coronary intervention 
TIMI: thrombolysis in myocardial infarction 
Out of hours: Monday to Friday 1800-0800 hours, and weekends 
Admission route: 
Direct: STEMI in the community taken directly to PPCI hospital 
Transfer: STEMI in the community taken to or self-presenting to non-PPCI hospital 
Non-PPCI IP: STEMI whilst an inpatient in a non-PPCI hospital  
PPCI IP: STEMI whilst an inpatient in a PPCI hospital 
Centre volume: Number of PPCI cases by centre  
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Factors associated with call to balloon time (table 2) 
CTB time was independently associated with age and was 13 minutes longer for patients aged 
over 80 than for those aged under 55. CTB time was 4 minutes longer in female patients and 
5 minutes in those with diabetes.  A requirement for mechanical ventilation before PPCI was 
associated with the greatest absolute effect on CTB with an increase of 33 minutes. 
 
CTB time was 10 minutes longer for patients presenting ‘out of hours’ than for patients 
presenting during normal working hours (‘in-hours’). Patients initially admitted to a hospital 
without PPCI capability and then transferred to a PPCI centre had 49 minutes longer mean 
CTB times than patients admitted directly from the community to a PPCI service. 
 
CTB time was 9 minutes shorter in centres doing fewer than 100 PPCI procedures compared 
to those doing 200 or more. Symptom to call time was not significantly associated with CTB 
time. 
 
Factors associated with 30-day mortality (table 3) 
In a univariable analysis each 30-minute increase in CTB time increased the hazard of 30-day 
mortality by around one fifth. In multivariable analysis there was strong evidence of an 
independent association between CTB time and 30-day mortality (trend test p<0.0001).  
 
Advancing age was independently associated with a progressive increase in 30-day mortality 
such that patients aged over 80 were at over three-fold higher risk of 30-day mortality than 
patients under the age of 55. In a univariable analysis female gender was associated with 
higher 30-day mortality but this is explained by women presenting at older ages than men 
(average age at presentation 69 versus 62 years, respectively) and after multivariable analysis 
gender was not associated with 30-day mortality. 
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Table 2. Multivariable associations with call to balloon time 
 
Variable 
 
Difference in mean call 
to balloon time - minutes 
(95%CI) 
P value 
Age group, years <55 
   55-≤60 
   60-≤65 
   65-≤70 
   70-≤75 
   75-≤80 
   80-≤85 
   >85 
 
0 
1 (-2, 3) 
2 (0, 4) 
4 (2, 6) 
8 (6, 11) 
11 (8, 13) 
13 (10, 15) 
14 (11, 18) 
<0.0001 
Gender   Male 
   Female 
 
0 
4 (2, 5) 
<0.0001 
Diabetes  No 
   Yes 
 
0 
5 (3, 7) 
<0.0001 
Cardiogenic shock No 
pre-PCI   Yes 
 
0 
5 (2, 8) 
0.0015 
Ventilated pre-PPCI No 
   Yes 
 
0 
33 (28, 37) 
<0.0001 
Q wave on ECG No 
   Yes 
 
0 
8 (6, 10) 
<0.0001 
TIMI flow pre-PPCI TIMI 0 
   TIMI 1 
   TIMI 2 
   TIMI 3 
 
0 
2 (0, 5) 
6 (3, 8) 
10 (7, 12) 
<0.0001 
Arterial access  Radial 
   Femoral 
   Joint/other 
 
0 
2 (0, 3) 
7 (2, 11) 
0.0007 
Out of hours  No 
   Yes 
 
0 
10 (8, 11) 
<0.0001 
 
Admission route Direct 
   Transfer 
   Non-PPCI IP 
   PPCI IP 
 
0 
49 (47, 51) 
9 (4, 13) 
-26 (-31, -22) 
<0.0001 
Centre volume  ≥200 
   100-199 
   <100 
 
0 
0 (-2, 3) 
-9 (-12, -7) 
 
<0.0001* 
 Trend test; CI confidence interval 
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Diabetes, peripheral vascular disease, renal disease, Q waves on the presenting ECG, multi-
vessel PCI, and femoral artery access were all independently associated with an increased risk 
of 30-day mortality. Cardiogenic shock and ventilation before PPCI had the greatest absolute 
independent effect on the hazard of 30-day mortality (table 3). 
 
The 49-minute increase in CTB time associated with inter-hospital transfer was associated 
with an observed 18% increase in the hazard of 30-day mortality (95% CI 0.99 to 1.39) but 
the evidence was not strong (p=0.059) (table 4). The 10-minute increase in CTB time 
associated with an ‘out of hours’ call time was not associated with an increase in 30-day 
mortality. 
 
The relationship between CTB time and predicted 30-day mortality at different levels of 
individual patient risk is shown in figure 4. For a patient at low risk (25th centile of risk), an 
increase in CTB time from 60 minutes to 360 minutes is predicted to increase 30-day 
mortality by less than 1%, whereas such a treatment delay among higher risk patients (75th 
centile of risk) is predicted to increase 30-day mortality by nearly 3% (figure 4). 
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Table 3. Multivariable associations with 30-day mortality 
Variable Hazard ratio (95%CI) P value 
Call to balloon (mins) ≤90 
   >90-120 
   >120-150 
   >150-180 
   >180-240 
   >240 
 
1 
1.14 (0.93, 1.39) 
1.26 (1.02, 1.56) 
1.21 (0.94, 1.57) 
1.95 (1.54, 2.47) 
1.41 (1.04, 1.90) 
<0.0001 
Age group, years <55 
   55-≤60 
   60-≤65 
   65-≤70 
   70-≤75 
   75-≤80 
   80-≤85 
   >85 
 
1 
1.36 (1.00, 1.84) 
1.62 (1.22, 2.15) 
1.54 (1.17, 2.04) 
2.15 (1.63, 2.83) 
2.72 (2.08, 3.56) 
3.88 (2.97, 5.06) 
6.36 (4.92, 8.23) 
<0.0001 
Gender   Male 
   Female 
 
1 
1.09 (0.94, 1.26) 
0.23 
Diabetes  No 
   Yes 
 
1 
1.42 (1.19, 1.70) 
0.0001 
PVD   No 
   Yes 
 
1 
2.02 (1.59, 2.58) 
<0.0001 
Renal disease  No 
   Yes 
 
1 
1.86 (1.34, 2.57) 
0.0002 
Cardiogenic shock No 
pre-PCI   Yes 
 
1 
5.21 (4.40, 6.16) 
<0.0001 
 
Ventilated pre-PCI No 
   Yes 
 
1 
3.76 (3.07, 4.60) 
<0.0001 
 
Q wave on ECG No 
   Yes 
 
1 
1.34 (1.14, 1.58) 
0.0003 
 
TIMI flow pre-PCI TIMI 0 
   TIMI 1 
   TIMI 2 
   TIMI 3 
 
1.54 (1.13, 2.08) 
1.38 (0.94, 2.04) 
1.06 (0.72, 1.56) 
1 
0.0004 
 
Number of  Single 
vessels attempted Multi 
 
1 
1.50 (1.26, 1.79) 
<0.0001 
 
Multi-vessel disease 1 vessel 
(>75% stenosis) ≥ 2 vessels 
 
1 
1.43 (1.23, 1.67) 
<0.0001 
Arterial access  Radial  
   Femoral 
   Joint/other 
1 
1.41 (1.21, 1.64) 
1.61 (1.17, 2.22) 
<0.0001 
 
 Trend test, CI confidence interval 
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Table 4. Relationship between out of hours PPCI, admission route, centre volume and 
components of symptom to balloon time with 30-day mortality (multivariable analysis) 
 
 CTB included in analysis 
 
CTB excluded from analysis 
 
Variable 
 
Hazard ratio 
(95%CI) 
P value Hazard ratio 
(95%CI) 
 
P value 
Out of hours No 
  Yes 
 
1 
1.00 (0.87, 1.15) 
 
0.99 
1 
1.04 (0.91, 1.20) 
 
0.52 
Admission route Direct 
  Transfer 
  Non-PPCI IP 
  PPCI IP 
 
1 
0.98 (0.81, 1.19) 
1.57 (1.06, 2.32) 
1.39 (0.96, 2.02) 
 
 
0.85 
0.023 
0.085 
1 
1.18 (0.99, 1.39) 
1.69 (1.15, 2.49) 
1.26 (0.87, 1.82) 
 
0.059 
0.007 
0.22 
Centre volume ≥200 
  100-199 
  <100 
 
1 
0.93 (0.73, 1.19) 
0.99 (0.79, 1.24) 
 
 
0.55 
0.91 
 
1 
0.91 (0.71, 1.16) 
0.91 (0.73, 1.13) 
 
 
0.46 
0.39 
 
Symptom to call (mins)** 
  ≤10 
  >10-30 
  >30-60 
  >60-120 
  >120-180 
  >180-360 
  >360 
 
 
1 
0.81 (0.65, 1.01) 
0.88 (0.70, 1.11) 
0.82 (0.65, 1.04) 
0.84 (0.63, 1.16) 
0.94 (0.71, 1.23) 
1.06 (0.83, 1.35) 
 
 
0.58* 
 
 
1 
0.83 (0.66, 1.04) 
0.90 (0.72, 1.13) 
0.82 (0.65, 1.05) 
0.88 (0.66, 1.17) 
0.96 (0.73, 1.26) 
1.08 (0.84, 1.38) 
 
 
0.47* 
Direct admission patients only*** 
Symptom to call (mins)* 
  ≤10-30 
  >30-60 
  >60-120 
  >120-180 
  >180 
 
Call to door (mins) 
  ≤60 
  >60-90 
  >90-120 
  >120 
 
Door to balloon (mins) 
  ≤60 
  >60-90 
  >90-120 
  >120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
0.98 (0.77, 1.25) 
0.89 (0.69, 1.15) 
1.06 (0.78, 1.43) 
1.14 (0.91, 1.42) 
 
 
1 
1.07 (0.89, 1.28) 
1.36 (1.04, 1.77) 
1.40 (0.96, 2.04) 
 
 
1 
1.04 (0.84, 1.29) 
1.54 (1.16, 2.06) 
1.43 (1.07, 1.93) 
 
 
0.38* 
 
 
 
 
 
 
0.0074* 
 
 
 
 
 
0.0008* 
CI confidence interval 
* Trend test 
** Among 16284 patients with symptom to call time available 
*** Among 12497 direct admission patients with symptom to call time available 
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Discussion 
 
We analysed data from a large contemporary series of patients with acute STEMI who were 
treated by a coordinated national PPCI service and identified several variables that were 
independently associated with CTB time and 30-day mortality. Some of these factors are 
unalterable (age, gender) but some are potentially modifiable (CTB time) suggesting scope to 
further improve the outcomes of PPCI. 
 
Previous studies have generally reported a positive association between treatment delay and 
mortality after PPCI for STEMI, but inconsistencies in the evidence base may reflect 
differences in study design, data collection periods, and definitions of treatment delay and 
outcomes. Early studies from the United States reported median DTB times of over 100 
minutes 6,9 and median symptom to balloon (STB) times of 234 minutes. 6 Recent studies 
have reported DTB times approaching 60 minutes but these improvements in STEMI care 
have not consistently been associated with improvements in outcome, 15-17 possibly because of 
the use of population rather than individual level treatment delays in some studies. 22  
 
DTB time may be a poor indicator of the overall impact of treatment delay on outcome, as it 
does not include pre-hospital care. The STB time is a measure of total ischaemic time, but 
symptom onset may be difficult to define accurately because of recall bias, prodromal anginal 
symptoms and silent or atypical presentations. By contrast CTB time is derived from two 
easily measured time points (time of call to emergency services or self-presentation at 
hospital, and time of therapeutic instrumentation of the culprit coronary artery), which are 
systematically recorded for all patients treated by PPCI in the UK. CTB time includes the 
potentially modifiable components of the system delay and may provide the best measure of 
the overall performance of a PPCI service. 
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In a previous study of 13,790 patients with STEMI, who were enrolled in the Swedish 
SCAAR registry from 2003-2008, the delay from first medical contact (FMC) to PPCI was 
associated with 1-year mortality and severe left ventricular systolic dysfunction at discharge 
from hospital. 23 The time of FMC, however, was defined by the time of the first 
electrocardiogram, which was recorded before arrival in hospital in only 51% of patients. 
Moreover the time of PPCI was determined by the start of the coronary arteriogram, rather 
than therapeutic instrumentation of the coronary artery. This may explain why the median 
time from FMC to PPCI in this study was only 70 minutes. Another study reported on 6,209 
patients treated by PPCI from 2002-2008 at three centres in Western Denmark.  CTB time 
was defined as the time from FMC with the emergency medical services to insertion of the 
guiding catheter before PPCI. CTB times following direct admission to the PPCI centre and 
following transfer from a local hospital were 97 and 139 minutes, respectively, and CTB time 
was independently associated with mortality at a median of 3.4 years.11In our study symptom 
to call time was not associated with 30-day mortality whereas call to door and door to balloon 
time were (table 4), suggesting pre-hospital and hospital based emergency care are equally 
important contributors to patient outcome. 
 
In our study the relationship between CTB time and mortality was influenced by patient risk 
profile, such that an increase in CTB time was predicted to have substantially greater impact 
on 30-day mortality among patients at high risk relative to those at low risk. Several variables 
associated with CTB time were also associated with 30-day mortality, suggesting that patients 
most likely to experience delays to treatment may also be most likely to benefit from efforts 
to minimize treatment delay. 
 
The results of PPCI outside of normal working hours have been studied extensively. A meta-
analysis of data from 1.9 million patients from 36 studies reported that ‘out of hours’ PPCI 
was associated with a 14.8-minute increase in DTB time and a 12% increase in the odds of in-
hospital and 30-day mortality. 24 Three large registries also reported that out of hours PPCI 
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was associated with longer DTB times but these treatment delays had no impact on in-
hospital mortality. 25-27 
 
In our study, an ‘out of hours’ call time was associated with an increase in CTB time of only 
10 minutes, which did not translate into an increase in 30-day mortality. These data suggest 
that the increase in CTB time associated with ‘out of hours’ procedures was insufficient to 
impact 30-day mortality, and support current models of PPCI service delivery across England 
and Wales. 
 
The shorter CTB times in ‘low volume’ centres (<100 PPCI procedures) may reflect 
opportunistic intervention in centres that do not provide a 24/7 service. Overall centre volume 
had no impact on 30-day mortality but this data requires cautious interpretation because it has 
limited statistical power.  
 
In England and Wales a minority of patients with STEMI self-present to a non-PPCI hospital 
or are initially taken to the nearest emergency department because of diagnostic uncertainty. 
These patients experience a 49-minute increase in CTB time, which is associated with a 18% 
increase in the hazard of 30-day mortality. These data support the need for preferential 
transfer of patients with suspected STEMI directly to a hospital with PPCI capability to 
minimize delays to treatment.  
 
In England and Wales over 80% of patients meet the national audit standard of a CTB time of 
less than 150 minutes.  Recent guidance from the National Institute of Health and Care 
Excellence (NICE) recommended that PPCI should be the preferred reperfusion strategy 
provided that PPCI can be delivered within 120 minutes of the time at which fibrinolysis 
could be given. 28 For most patients the CTB time includes the time from the call for help to 
the arrival of an ambulance, the time to make a diagnosis and the time that would have been 
required to set up a fibrinolytic infusion. Cumulatively these delays are likely to exceed 30 
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minutes; hence the majority of patients in this study would have been compliant with the 
NICE guidelines. Long CTB times may be unavoidable in patients who present in 
geographically remote areas, in whom ambulance transfer is delayed or where there is 
diagnostic uncertainty at the time of presentation. Future research should focus on this 
subgroup and if CTB times cannot be shortened pharmaco-invasive treatment may be an 
alternative strategy. 29, 30 
 
Limitations 
 
We assessed the impact of patient specific CTB times on 30-day mortality in a large cohort of 
patients undergoing PPCI in a single year. Substantial variation in observed and unobserved 
factors during this period is unlikely but residual confounding by factors not included in the 
multivariable analyses cannot be excluded.  
 
Our data suggest that CTB time is a useful metric to evaluate the performance of PPCI 
services and has advantages over DTB time. Nevertheless, CTB time may not be a reliable 
surrogate for total ischaemic time because of variation in the duration and severity of 
symptoms before the person calls for help, and because the time of the first therapeutic 
intervention on the occluded coronary artery may not completely reperfuse the affected 
myocardium. 
 
We report outcome at 30 days and most deaths after PPCI occur within this time window but 
longer term follow up data may provide additional information. In addition, our study only 
included patients treated by PPCI and is not applicable to patients with STEMI who are 
managed with fibrinolysis or do not receive reperfusion therapy, who may have worse 
outcomes. 5,31 
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Conclusions 
 
In this contemporary study of patients treated by PPCI within an established national system 
of STEMI care there was a strong independent association between CTB time and 30-day 
mortality. This relationship was influenced by patient risk profile and in high-risk patients an 
increase in CTB time of 90 minutes would be expected to increase 30-day mortality by 
around 1%. 
 
Approximately 20% of patients have CTB times longer than 150 minutes and further research 
is required to determine the causes of treatment delay in this subgroup. Efforts to improve 
performance of PPCI services should ensure that all patients with STEMI are preferentially 
directed to a hospital with PPCI capability so that the route of entry into the healthcare system 
does not influence outcomes. 
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Figure legends 
 
Figure 1: Patient selection 
Abbreviations: BCIS British Cardiovascular Intervention Society; PCI Percutaneous coronary 
intervention; PPCI Primary percutaneous coronary intervention; STEMI ST segment 
elevation myocardial infarction. 
Duplicates refers to duplicate records 
Repeat PPCI refers to a repeat PPCI procedure in the same year 
 
 
Figure 2: Frequency of call to balloon times. Each bar represents a 15-minute interval  
 
 
Figure 3: Kaplan-Meier plot of 30 day mortality by call to balloon time (with 90 and 150 
minutes as cut-points) 
 
 
Figure 4: Association between call to balloon time and 30-day mortality 
 
 
 
 
 
 
 
